| Code | Description | Claims | Beneficiaries | Total Paid |
| H2036 |
Alcohol and/or other drug treatment program, per diem |
66,682 |
3,484 |
$13.12M |
| H0011 |
Alcohol and/or drug services; acute detoxification (residential addiction program inpatient) |
13,075 |
3,246 |
$5.87M |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
16,083 |
2,717 |
$1.89M |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
3,464 |
577 |
$725K |
| S9480 |
Intensive outpatient psychiatric services, per diem |
7,126 |
1,154 |
$660K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
15,743 |
6,835 |
$316K |
| 90791 |
Psychiatric diagnostic evaluation |
1,790 |
1,559 |
$193K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,293 |
1,645 |
$142K |
| 90837 |
Psychotherapy, 53 minutes with patient |
383 |
154 |
$34K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
421 |
281 |
$28K |
| 99205 |
Prolong outpt/office vis |
46 |
43 |
$8K |
| 99215 |
Prolong outpt/office vis |
60 |
30 |
$7K |
| 90834 |
Psychotherapy, 45 minutes with patient |
85 |
16 |
$5K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
71 |
44 |
$3K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
1,598 |
814 |
$0.00 |
| H0047 |
Alcohol and/or other drug abuse services, not otherwise specified |
17,117 |
936 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,392 |
1,213 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
598 |
544 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,990 |
1,984 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,972 |
1,974 |
$0.00 |
| H0018 |
Behavioral health; short-term residential (non-hospital residential treatment program), without room and board, per diem |
327 |
22 |
$0.00 |